The updated COVID-19 vaccine from vaccine manufacturer Novavax (Nuvaxovid) will also be available in Austria from ...

In addition to flu vaccines for the general public and RSV vaccines for older adults and pregnant people, new COVID vaccines from Pfizer-BioNTech, Moderna and Novavax are available this season to ...

Updates will be announced once regulatory approval has been successfully filed by Novavax. Read more at straitstimes.com.

Here’s what to know about the 2024-2025 vaccines — what’s available, how the updated versions are tested, how well each protects you, side effects and other safety information, the best time to get ...

On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said he is ‘not a fan' of Novavax, Inc. NVAX. On Dec. 4, Novavax agreed ...

Novavax sells its Czech Republic facility to Novo Nordisk, boosting its vaccine pipeline while cutting costs, as Novo expands ...

Novavax reported a net loss of $0.76/share and $84.5M in revenue, beating estimates but cutting guidance due to lower COVID-19 vaccine sales. Revenue has declined since 2022, prompting a ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Novavax, Inc. (Symbol: NVAX) entered into oversold territory, hitting an RSI reading of 28. ...

Novavax (NVX-CoV2373) is a brand-name vaccine that’s prescribed to help prevent COVID-19. As with other drugs, Novavax can cause side effects, such as pain or swelling at the injection site ...

Matrix-M™ adjuvant, today announced that the first participants have been dosed in its COVID-19-Influenza Combination (CIC) and stand-alone seasonal influenza Phase 3 trial. The trial will evaluate ...